These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7967683)

  • 41. Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review.
    Boer C; Meesters MI; Veerhoek D; Vonk ABA
    Br J Anaesth; 2018 May; 120(5):914-927. PubMed ID: 29661409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass.
    Shigeta O; Kojima H; Hiramatsu Y; Jikuya T; Terada Y; Atsumi N; Sakakibara Y; Nagasawa T; Mitsui T
    J Thorac Cardiovasc Surg; 1999 Aug; 118(2):354-60. PubMed ID: 10425010
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison between arterial- and venous-sampled activated clotting time measurements.
    Zisman E; Rozenberg B; Katz Y; Ziser A
    Isr J Med Sci; 1997 Dec; 33(12):786-8. PubMed ID: 9464347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protamine overdose and its impact on coagulation, bleeding, and transfusions after cardiopulmonary bypass: results of a randomized double-blind controlled pilot study.
    Koster A; Börgermann J; Gummert J; Rudloff M; Zittermann A; Schirmer U
    Clin Appl Thromb Hemost; 2014 Apr; 20(3):290-5. PubMed ID: 23564056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass.
    Levin AI; Heine AM; Coetzee JF; Coetzee A
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):224-9. PubMed ID: 24461364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
    Dyke CM; Smedira NG; Koster A; Aronson S; McCarthy HL; Kirshner R; Lincoff AM; Spiess BD
    J Thorac Cardiovasc Surg; 2006 Mar; 131(3):533-9. PubMed ID: 16515902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hand-held personal digital assistant program for the HEMOCHRON RxDx heparin and protamine dosing system.
    El Rouby S; Rinehart K; Zucker ML; LaDuca FM
    J Extra Corpor Technol; 2003 Sep; 35(3):212-7. PubMed ID: 14653423
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Pharmacokinetic Model for Protamine Dosing After Cardiopulmonary Bypass.
    Meesters MI; Veerhoek D; de Jong JR; Boer C
    J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1190-5. PubMed ID: 27493093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
    Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Con: The Hepcon HMS Should Not Be Used Instead of Traditional Activated Clotting Time to Dose Heparin and Protamine for Cardiac Surgery Requiring Cardiopulmonary Bypass.
    Gilly G; Trusheim J
    J Cardiothorac Vasc Anesth; 2016 Dec; 30(6):1730-1732. PubMed ID: 27751763
    [No Abstract]   [Full Text] [Related]  

  • 51. Management of postoperative heparin rebound following cardiopulmonary bypass.
    Pifarré R; Babka R; Sullivan HJ; Montoya A; Bakhos M; El-Etr A
    J Thorac Cardiovasc Surg; 1981 Mar; 81(3):378-81. PubMed ID: 7464201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pro: The Hepcon HMS Should Be Used Instead of Traditional Activated Clotting Time (ACT) to Dose Heparin and Protamine for Cardiac Surgery Requiring Cardiopulmonary Bypass.
    Ural K; Owen C
    J Cardiothorac Vasc Anesth; 2016 Dec; 30(6):1727-1729. PubMed ID: 27641953
    [No Abstract]   [Full Text] [Related]  

  • 53. Evaluation of Activated Clotting Times With a Heparin Reversal Protocol Designed to Conserve Protamine During Drug Shortages: A Retrospective, Cohort Study.
    Fabbro M; Salas ASL; Parker KN; Lamelas J; Epstein RH
    J Cardiothorac Vasc Anesth; 2023 Sep; 37(9):1618-1623. PubMed ID: 37302932
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PEG-modified protamine with improved pharmacological/pharmaceutical properties as a potential protamine substitute: synthesis and in vitro evaluation.
    Chang LC; Lee HF; Chung MJ; Yang VC
    Bioconjug Chem; 2005; 16(1):147-55. PubMed ID: 15656586
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of heparin and protamine in presence of overdosage: in vitro study.
    Hanke AA; Severloh I; Flöricke F; Weber CF; Lang T
    Asian Cardiovasc Thorac Ann; 2021 Jan; 29(1):5-9. PubMed ID: 32854516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In Vivo Protamine Titration Using Activated Coagulation Time to Neutralize Heparin Anticoagulation in Cardiac Surgery: Proof of Concept.
    Rochon AG; Bélisle S; Couture P; Fortier A; Lebon JS; Deschamps A
    J Cardiothorac Vasc Anesth; 2020 Sep; 34(9):2369-2374. PubMed ID: 32014311
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph.
    Khan NU; Wayne CK; Barker J; Strang T
    Eur J Anaesthesiol; 2010 Jul; 27(7):624-7. PubMed ID: 20485179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of two protocols for heparin neutralization by protamine after cardiopulmonary bypass.
    Arén C; Feddersen K; Rådegran K
    J Thorac Cardiovasc Surg; 1987 Oct; 94(4):539-41. PubMed ID: 3309479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heparin monitoring during cardiopulmonary bypass.
    Saleem A; Shenaq SS; Yawn DH; Harshberger K; Diemunsch P; Mohindra P
    Ann Clin Lab Sci; 1984; 14(6):474-9. PubMed ID: 6508227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.
    Gatt A; van Veen JJ; Woolley AM; Kitchen S; Cooper P; Makris M
    Thromb Haemost; 2008 Aug; 100(2):350-5. PubMed ID: 18690358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.